Korea 2018 Review: Hopes And Worries Coexist In Pharma Sector
Executive Summary
As the year end approaches, Scrip wraps up what major events made headlines in the South Korean pharma/biotech sector in 2018.
Advertisement
Related Content
Topics
- Regions
- Asia Pacific
- Subjects
- Commercial
- Policy & Regulation
- Industries
- BioPharmaceutical
Related Companies
- Samsung BioLogics
- Samsung Bioepis Co. Ltd.
- Yuhan Corp.
- Janssen Biotech Inc.
- Roivant Sciences Inc.
- ABL Bio Corp.
- TRIGR Therapeutics Inc.
- Kolon Life Science Inc.
- Mitsubishi Tanabe Pharma Corp.
- GC Pharma
- Celltrion Inc.
- Chong Kun Dang Pharmaceutical Corp.
- Alteogen Inc.
- LG Chem
- SK Biopharmaceuticals Co. Ltd.
Advertisement
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
SC124347
Ask The Analyst
Please Note: Click here for more information on the Ask the Analyst service.
Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.
All fields are required.
SC124347
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.